Latest AI and machine learning research in leukemia for healthcare professionals.
Causal Deep/Machine Learning (CDL/CML) is an emerging Artificial Intelligence (AI) paradigm. The com...
Heterogeneity in chronic malignancies raises an increasing interest for the integration and study of...
Early identification of patients at high risk of cardiac surgery-associated acute kidney injury (CSA...
BACKGROUND: Tumor mutation burden (TMB) and VHL mutation play a crucial role in the management of pa...
Cell-cell communications is crucial for the regulation of cellular life and the establishment of cel...
Myelodysplastic syndrome (MDS) frequently transforms into acute myeloid leukemia (AML). Predicting t...
Graph-based learning approaches, due to their ability to encode tissue/organ structure information, ...
This study explores the feasibility of employing eXplainable Artificial Intelligence (XAI) methodolo...
The progression of lung adenocarcinoma (LUAD) from atypical adenomatous hyperplasia (AAH) to invasiv...
With advances in artificial intelligence, machine learning (ML) has been widely applied to predict f...
Subdural hematoma is defined as blood collection in the subdural space between the dura mater and ar...
BACKGROUND/AIM: While post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) benefits pa...
BACKGROUND: Acute leukaemias are life-threatening haematological cancers characterised by the infilt...
The demand for Janus Kinase-2 (JAK2) testing has been disproportionate to the low yield of positive ...
PURPOSE: Adverse effects of chemotherapy often require hospital admissions or treatment management. ...
The U.S. Government is committed to maintaining a robust research program that supports a portfolio ...
Predicting the drug response of cancer cell lines is crucial for advancing personalized cancer treat...